Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 December;54(6) > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 December;54(6):677-88

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

ORIGINAL ARTICLES  


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 December;54(6):677-88

language: English

Comparison of two region of interest definition methods for metabolic response evaluation with [18F]FDG-PET

Vriens D. 1, De Geus-Oei L. F. 1, Van Laarhoven H. W. M. 2, Van Der Heijden H. F. M. 3, Krabbe P. F. M. 4, Visser E. P. 1, Oyen W. J. G. 1

1 Department of Nuclear Medicine, Radboud University, Nijmegen Medical Center, Nijmegen, the Netherlands;
2 Department of Medical Oncology, Radboud University, Nijmegen Medical Center, Nijmegen, the Netherlands;
3 Department of Pulmonary Diseases, Radboud University, Nijmegen Medical Center, Nijmegen, the Netherlands;
4 Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University, Nijmegen Medical Centre, Nijmegen, the Netherlands


PDF  


AIM: In therapy response monitoring by [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET), different tumor delineations are used, resulting in different values for change in glucose metabolic rate (DMRglu). We propose a technique to compare metabolic rates in a region of interest (ROI) based on fixed volumes rather than on fixed thresholds. This method involves change in lesion size.
METHODS: In 49 patients with colorectal carcinoma (CRC) and 50 patients with non-small cell lung carcinoma (NSCLC) scheduled for chemotherapy, FDG-PET was performed at baseline and during chemotherapy. A ROIfixed thresholds was determined by using a 50% threshold on both baseline and follow-up FDG-PET. A ROIfixed volumes was determined by using a 50% threshold, determined on the series with the largest tumor volume. This ROIfixed volumes is used on consecutive scans. Predictive effects of both methods were investigated by survival analysis for overall and progression free survival.
RESULTS: In CRC, only ROIfixed volumes based DMRglu showed significant predictive ability. In NSCLC, both techniques showed significant predictive ability. During multivariate analysis, ROIfixed volumes determined DMRglu was an independent predictor for both overall and progression free survival in NSCLC whereas ROIfixed thresholds determined MRglu was not. After dichotomization at the median DMRglu, median survival ratio was higher in ROIfixed volumes than ROIfixed thresholds for CRC (overall survival: 1.78 vs 1.25, progression free survival: 1.57 vs 1.21) and NSCLC (overall survival: 2.01 vs 2.01, progression free survival: 2.93 vs 2.13).
CONCLUSION: ROIfixed volumes based DMRglu shows better correlation with survival than DMRglu determined from a ROIfixed thresholds.

top of page

Publication History

Cite this article as

Corresponding author e-mail

D.Vriens@nucmed.umcn.nl